tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

PHRRF Stock Latest News

PharmaTher Secures FDA Meeting for Ketamine Drug
Company AnnouncementsPharmaTher Secures FDA Meeting for Ketamine Drug
1d ago
PharmaTher granted post-CRL clarification meeting request by FDA
PremiumThe Fly
PharmaTher granted post-CRL clarification meeting request by FDA
1d ago
PharmaTher Faces FDA Setback for Ketamine Drug
PremiumCompany Announcements
PharmaTher Faces FDA Setback for Ketamine Drug
22d ago
PharmaTher receives CRL from FDA for ketamine ANDA
PremiumThe Fly
PharmaTher receives CRL from FDA for ketamine ANDA
22d ago
PharmaTher Closes in on FDA Ketamine Approval Date
PremiumCompany Announcements
PharmaTher Closes in on FDA Ketamine Approval Date
2M ago
PharmaTher receives GDUFA goal date of October 29 for ketamine NDA
PremiumThe FlyPharmaTher receives GDUFA goal date of October 29 for ketamine NDA
2M ago
PharmaTher’s Potential Breakthrough in Monkeypox Treatment
Premium
Company Announcements
PharmaTher’s Potential Breakthrough in Monkeypox Treatment
3M ago
PharmaTher’s Sairiyo Advances with Clinical Trial Approval
Premium
Company Announcements
PharmaTher’s Sairiyo Advances with Clinical Trial Approval
3M ago
PharmaTher’s Sairiyo receives approval to initiate Phase 1 trial of PD-001
PremiumThe Fly
PharmaTher’s Sairiyo receives approval to initiate Phase 1 trial of PD-001
3M ago
PharmaTher Advances Clinical Trials for New Treatment
PremiumCompany Announcements
PharmaTher Advances Clinical Trials for New Treatment
6M ago
PharmaTher’s Sairiyo submits CTA for Phase 1 study of cepharanthine
PremiumThe Fly
PharmaTher’s Sairiyo submits CTA for Phase 1 study of cepharanthine
6M ago
PharmaTher Nears FDA Decision on Ketamine Application
PremiumCompany Announcements
PharmaTher Nears FDA Decision on Ketamine Application
6M ago
PharmaTher announces assigned GDUFA goal data for Ketamine ANDA
PremiumThe FlyPharmaTher announces assigned GDUFA goal data for Ketamine ANDA
6M ago
PharmaTher Advances Cepharanthine Phase 1 Trials
Premium
Company Announcements
PharmaTher Advances Cepharanthine Phase 1 Trials
7M ago
PharmaTher’s Sairiyo completes package for Phase 1 study of cepharanthine
Premium
The Fly
PharmaTher’s Sairiyo completes package for Phase 1 study of cepharanthine
7M ago
PharmaTher Optimistic on Resolving Ketamine Shortage
PremiumCompany Announcements
PharmaTher Optimistic on Resolving Ketamine Shortage
7M ago
PharmaTher Closer to Resolving US Ketamine Shortage
PremiumCompany Announcements
PharmaTher Closer to Resolving US Ketamine Shortage
7M ago
PharmaTher provides update on priority original ANDA for ketamine
PremiumThe Fly
PharmaTher provides update on priority original ANDA for ketamine
7M ago
Revive provides update on psilocybin study for methamphetamine use disorder
PremiumThe Fly
Revive provides update on psilocybin study for methamphetamine use disorder
8M ago
PharmaTher: FDA provides preliminary thoughts on possible deficiencies for ANDA
PremiumThe FlyPharmaTher: FDA provides preliminary thoughts on possible deficiencies for ANDA
9M ago
PharmaTher provides update for expected FDA approval of ketamine
Premium
The Fly
PharmaTher provides update for expected FDA approval of ketamine
10M ago
PharmaTher announces FDA acceptance of ANDA for KETARX
Premium
The Fly
PharmaTher announces FDA acceptance of ANDA for KETARX
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >